COMMUNIQUÉS West-GlobeNewswire
-
45,611 Orion Corporation A shares converted into B shares
15/07/2026 -
WONDERLAB Spotlights Gut Health and Innate Immunity, Featuring Its Proprietary Strain GOLDGUT-M520
15/07/2026 -
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
15/07/2026 -
CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population
15/07/2026 -
Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
15/07/2026 -
Closing of Previously Announced Restructuring Transaction in Connection with CCAA Proceedings
15/07/2026 -
Spire Healthcare announced as exclusive Team GB Official Healthcare Services Partner
15/07/2026 -
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases
14/07/2026 -
Spur Therapeutics Announces Executive Transitions
14/07/2026 -
Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
14/07/2026 -
Acquisition of Own Shares
14/07/2026 -
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
14/07/2026 -
Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026
14/07/2026 -
Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026
14/07/2026 -
AVITA Medical to Announce Second Quarter 2026 Financial Results
14/07/2026 -
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
14/07/2026 -
Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight
14/07/2026 -
ORIC® Pharmaceuticals Announces Initiation of Himalayas-1 Phase 3 Trial in mCRPC Evaluating Rinzimetostat in Combination with NUBEQA® (Darolutamide), Supported by Clinical Collaboration with Bayer
14/07/2026 -
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
14/07/2026
Pages